Drugs / Insulex® R
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07364669 | Oct 2024 → Feb 2025 | — | Laboratorios PiSA | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Insulex R | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07364669 ↗ |
| Modality | Protein / enzyme biologic | “recombinant human rapid-acting insulin option” NCT07364669 ↗ |
| Route | Subcutaneous | “single subcutaneous injection of 0.3 IU/kg body weight” NCT07364669 ↗ |